Regulation of Indoleamine 2,3-Dioxygenase Expression in Simian Immunodeficiency Virus-Infected Monkey Brains

ABSTRACT The human immunodeficiency virus type 1-associated cognitive-motor disorder, including the AIDS dementia complex, is characterized by brain functional abnormalities that are associated with injury initiated by viral infection of the brain. Indoleamine 2,3-dioxygenase (IDO), the first and rate-limiting enzyme in tryptophan catabolism in extrahepatic tissues, can lead to neurotoxicity through the generation of quinolinic acid and immunosuppression and can alter brain chemistry via depletion of tryptophan. Using the simian immunodeficiency virus (SIV)-infected rhesus macaque model of AIDS, we demonstrate that cells of the macrophage lineage are the main source for expression of IDO in the SIV-infected monkey brain. Animals with SIV encephalitis have the highest levels of IDO mRNA, and the level of IDO correlates with gamma interferon (IFN-γ) and viral load levels. In vitro studies on mouse microglia reveal that IFN-γ is the primary inducer of IDO expression. These findings demonstrate the link between IDO expression, IFN-γ levels, and brain pathology signs observed in neuro-AIDS.

[1]  S. Henriksen,et al.  Highly Activated CD8+ T Cells in the Brain Correlate with Early Central Nervous System Dysfunction in Simian Immunodeficiency Virus Infection1 , 2001, The Journal of Immunology.

[2]  Xavier Alvarez,et al.  Central nervous system perivascular cells are immunoregulatory cells that connect the CNS with the peripheral immune system , 2001, Glia.

[3]  J. McArthur,et al.  HIV in the brain , 2001, Neurology.

[4]  M. Seishima,et al.  Lipopolysaccharide induction of indoleamine 2,3‐dioxygenase is mediated dominantly by an IFN‐γ‐independent mechanism , 2001, European journal of immunology.

[5]  F. Romerio,et al.  Human primary CD4 + T cells activated in the presence of IFN-alpha 2b express functional indoleamine 2,3-dioxygenase. , 2001, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[6]  T. Jernigan,et al.  Elevated cerebrospinal fluid quinolinic acid levels are associated with region-specific cerebral volume loss in HIV infection. , 2001, Brain : a journal of neurology.

[7]  H. McClure,et al.  Sensitive and robust one-tube real-time reverse transcriptase-polymerase chain reaction to quantify SIV RNA load: comparison of one- versus two-enzyme systems. , 2000, AIDS research and human retroviruses.

[8]  D. Fuchs,et al.  Interferon-gamma-induced tryptophan degradation: neuropsychiatric and immunological consequences. , 2000, Current drug metabolism.

[9]  K. Wittern,et al.  Comparative quantification of IL-1β, IL-10, IL-10r, TNFα and IL-7 mRNA levels in UV-irradiated human skin in vivo , 2000, Inflammation Research.

[10]  Hassan Mohammad Naif,et al.  Induction of Indolamine 2,3-Dioxygenase in Primary Human Macrophages by Human Immunodeficiency Virus Type 1 Is Strain Dependent , 2000, Journal of Virology.

[11]  Milton W. Taylor,et al.  Indoleamine 2,3-Dioxygenase Production by Human Dendritic Cells Results in the Inhibition of T Cell Proliferation , 2000, The Journal of Immunology.

[12]  J. Schmitz,et al.  A nonhuman primate model for the selective elimination of CD8+ lymphocytes using a mouse-human chimeric monoclonal antibody. , 1999, The American journal of pathology.

[13]  P. Portegies,et al.  Increased peroxynitrite activity in AIDS dementia complex: implications for the neuropathogenesis of HIV-1 infection. , 1999, Journal of immunology.

[14]  V. ter meulen,et al.  Protective Role of the Virus-Specific Immune Response for Development of Severe Neurologic Signs in Simian Immunodeficiency Virus-Infected Macaques , 1998, Journal of Virology.

[15]  D. Munn,et al.  Prevention of allogeneic fetal rejection by tryptophan catabolism. , 1998, Science.

[16]  A. Lackner,et al.  Sources of the neurotoxin quinolinic acid in the brain of HIV-1-infected patients and retrovirus-infected macaques. , 1998, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[17]  E. Masliah,et al.  Dendritic injury is a pathological substrate for human immunodeficiency virus—related cognitive disorders , 1997, Annals of neurology.

[18]  E. Major,et al.  Different kynurenine pathway enzymes limit quinolinic acid formation by various human cell types. , 1997, The Biochemical journal.

[19]  C. Coe,et al.  Quinolinic acid and lymphocyte subsets in the intrathecal compartment as biomarkers of SIV infection and simian AIDS. , 1997, AIDS research and human retroviruses.

[20]  V G Sasseville,et al.  Chemokine expression in simian immunodeficiency virus-induced AIDS encephalitis. , 1996, The American journal of pathology.

[21]  P. Ricciardi-Castagnoli,et al.  Regulation of the Kynurenine Metabolic Pathway by Interferon‐γ in Murine Cloned Macrophages and Microglial Cells , 1996, Journal of neurochemistry.

[22]  D. Munn,et al.  Selective activation-induced apoptosis of peripheral T cells imposed by macrophages. A potential mechanism of antigen-specific peripheral lymphocyte deletion. , 1996, Journal of immunology.

[23]  J. Glass,et al.  Immunocytochemical quantitation of human immunodeficiency virus in the brain: Correlations with dementia , 1995, Annals of neurology.

[24]  D. Kleiner,et al.  Increased human immunodeficiency virus (HIV) type 1 DNA content and quinolinic acid concentration in brain tissues from patients with HIV encephalopathy. , 1995, The Journal of infectious diseases.

[25]  H. Fox,et al.  Simian immunodeficiency virus (SIV)-specific CTL in cerebrospinal fluid and brains of SIV-infected rhesus macaques. , 1995, Journal of immunology.

[26]  Howard E. Gendelman,et al.  Dementia Associated with the Acquired Immunodeficiency Syndrome , 1995 .

[27]  H. Fox,et al.  Transfer of neuropathogenic simian immunodeficiency virus with naturally infected microglia. , 1995, The American journal of pathology.

[28]  G. Reynolds,et al.  Frontal cortex indoleamine-2,3-dioxygenase activity is increased in HIV-1-associated dementia , 1995, Neuroscience Letters.

[29]  E. Murray,et al.  Cytopathologic and Neurochemical Correlates of Progression to Motor/Cognitive Impairment in SIV-lnfected Rhesus Monkeys , 1994, Journal of neuropathology and experimental neurology.

[30]  J. Glass,et al.  Intracerebral cytokine messenger RNA expression in acquired immunodeficiency syndrome dememtia , 1993, Annals of neurology.

[31]  M. Demitrack,et al.  Quinolinic acid and kynurenine pathway metabolism in inflammatory and non-inflammatory neurological disease. , 1992, Brain : a journal of neurology.

[32]  E. Murray,et al.  Cognitive and motor impairments associated with SIV infection in rhesus monkeys. , 1992, Science.

[33]  A. Lackner,et al.  Localization of simian immunodeficiency virus in the central nervous system of rhesus monkeys. , 1991, The American journal of pathology.

[34]  E. Masliah,et al.  Neocortical damage during HIV infection , 1991, Annals of neurology.

[35]  S. Henriksen,et al.  Antiviral treatment normalizes neurophysiological but not movement abnormalities in simian immunodeficiency virus-infected monkeys. , 2000, The Journal of clinical investigation.

[36]  K. Wittern,et al.  Comparative quantification of IL-1beta, IL-10, IL-10r, TNFalpha and IL-7 mRNA levels in UV-irradiated human skin in vivo. , 2000, Inflammation research : official journal of the European Histamine Research Society ... [et al.].

[37]  L. Montagnier,et al.  Viral load and neuropathology in the SIV model. , 1999, Journal of neurovirology.

[38]  C. MacKenzie,et al.  Cytokine mediated regulation of interferon-gamma-induced IDO activation. , 1999, Advances in experimental medicine and biology.

[39]  M. Buchmeier,et al.  Expression of Inflammatory Cytokines and Inducible Nitric Oxide Synthase in Brains of SIV-Infected Rhesus Monkeys: Applications to HIV-Induced Central Nervous System Disease , 1996, Molecular medicine.

[40]  U. Hadding,et al.  Anti-parasitic effector mechanisms in human brain tumor cells: role of interferon-gamma and tumor necrosis factor-alpha. , 1996, European journal of immunology.

[41]  S. Lipton,et al.  Seminars in medicine of the Beth Israel Hospital, Boston. Dementia associated with the acquired immunodeficiency syndrome. , 1995, The New England journal of medicine.

[42]  V. Kruys,et al.  Tumor necrosis factor-alpha production induced by viruses and by lipopolysaccharides in macrophages: similarities and differences. , 1995, Journal of inflammation.

[43]  K Kure,et al.  Morphology and distribution of HIV-1 gp41-positive microglia in subacute AIDS encephalitis. Pattern of involvement resembling a multisystem degeneration. , 1990, Acta neuropathologica.